Co-Authors
This is a "connection" page, showing publications co-authored by LAXMAN DEVKOTA and ANDREW BADACHHAPE.
Connection Strength
1.291
-
Ferumoxytol-enhanced MRI of retroplacental clear space disruption in placenta accreta spectrum. Placenta. 2025 Feb; 160:100-106.
Score: 0.236
-
Feasibility Study of Ferumoxtyol for Contrast-enhanced MRI of Retroplacental Clear Space Disruption in Placenta Accreta Spectrum (PAS). medRxiv. 2023 Mar 24.
Score: 0.209
-
Nanoparticle Contrast-enhanced MRI for Visualization of Retroplacental Clear Space Disruption in a Mouse Model of Placental Accreta Spectrum (PAS). Acad Radiol. 2023 Jul; 30(7):1384-1391.
Score: 0.202
-
Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease. Sci Rep. 2020 09 30; 10(1):16185.
Score: 0.176
-
Nanoparticle Contrast-enhanced T1-Mapping Enables Estimation of Placental Fractional Blood Volume in a Pregnant Mouse Model. Sci Rep. 2019 12 10; 9(1):18707.
Score: 0.166
-
Pre-clinical magnetic resonance imaging of retroplacental clear space throughout gestation. Placenta. 2019 02; 77:1-7.
Score: 0.156
-
Nanoparticle contrast-enhanced computed tomography and magnetic resonance imaging of vascularization of a subcutaneous niche for islet transplantation. Bioeng Transl Med. 2025 May; 10(3):e10740.
Score: 0.059
-
A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging. Theranostics. 2022; 12(12):5504-5521.
Score: 0.050
-
A Hyperfluorinated Hydrophilic Molecule for Aqueous 19F MRI Contrast Media. Contrast Media Mol Imaging. 2018; 2018:1693513.
Score: 0.039